See the difference! Customize Seeking Alpha:
Sign in or join
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
(ZIOP)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: ZIOP
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Comments on ZIOP
Ziopharm: The Money's in the Bank, So What's Next?
[View article]
Oncology drugs are not generally marketed directly to the consumer. I agree, evidenced based care will become the norm. The US and...
More »
Comment by
Wall Street Teacher
Dec 29 14:29 pm
|
Rating:
0
0
Ziopharm: The Money's in the Bank, So What's Next?
[View article]
I don't recommend investing in biotech of any means. The salad days are over. More scrutiny is going to be placed into evidence based...
More »
Comment by
ksmithdc
Dec 12 12:01 pm
|
Rating:
0
0
Ziopharm: The Money's in the Bank, So What's Next?
[View article]
Two directors filed Form 4s tonight. One bought 50,000 units of the deal and the other bought 175,000. I'm betting my (meager) funds...
More »
Comment by
Wall Street Teacher
Dec 11 19:27 pm
|
Rating:
0
0
Ziopharm: The Money's in the Bank, So What's Next?
[View article]
Teacher, Thanks for the great information.... I too was not happy with the dilution but went ahead and added to my existing position...
More »
Comment by
willydo
Dec 11 19:12 pm
|
Rating:
0
0
Ziopharm Oncology: Step by Step
[View article]
I concur with your sentiments re: dilution and a short term cap on the stock price. I believe the choice to finance may have been their...
More »
Comment by
Wall Street Teacher
Dec 8 09:26 am
|
Rating:
0
0
Buyout Buzz at ASH Hematology Confab
[View article]
Long and still hopeful on ZIOP. The dilution was painful but hopefully this makes them well capitalized nenogh to now be taken seriously...
More »
Comment by
Wall Street Teacher
Dec 7 20:05 pm
|
Rating:
+1
0
Ziopharm Oncology: Step by Step
[View article]
Any new thoughts now that ZIOP has completed the very dilutive secondary raising $45 million. Seems like on the one hand this gives...
More »
Comment by
cygnusx1
Dec 5 10:17 am
|
Rating:
0
0
Ziopharm Oncology: Step by Step
[View article]
Thanks for the information, Teacher. I at least have a bit of an idea what could be expected. Regards, Willydo
Comment by
willydo
Nov 14 19:33 pm
|
Rating:
0
0
Ziopharm Oncology: Step by Step
[View article]
Very tough to speculate on that one. It depends on the type and timing of ny potential partnering arrangement and if they will need to...
More »
Comment by
Wall Street Teacher
Nov 14 12:30 pm
|
Rating:
0
0
Ziopharm Oncology: Step by Step
[View article]
I have held ZIOP for about 1.5 years and try to keep up with any news and the news has been encouraging lately. I would be interested...
More »
Comment by
willydo
Nov 12 20:59 pm
|
Rating:
0
0
BioMed News Bytes: Progenics, Somanetics, Ziopharm, Cardium, pSivida, BioMimetic Therapeutics
[View article]
LONG ZIOPHARM. iNTERSTING COMPANY.Hopefully the success in the clinic will translate into a commercial pairing. They also have an...
More »
Comment by
Wall Street Teacher
Oct 18 20:23 pm
|
Rating:
0
0
BioMed News Bytes: Progenics, Somanetics, Ziopharm, Cardium, pSivida, BioMimetic Therapeutics
[View article]
atlantis43, it currently contains 412 entries, last updated by me to reflect FDA Advisory Panel meeting today on Acorda's experimental...
More »
Comment by
Mike Havrilla
Oct 14 17:40 pm
|
Rating:
0
0
BioMed News Bytes: Progenics, Somanetics, Ziopharm, Cardium, pSivida, BioMimetic Therapeutics
[View article]
what ever happened to the FDA approval calendar that Mike Havrilla edited?
Comment by
atlantis43
Oct 14 17:28 pm
|
Rating:
0
0
Ziopharm Oncology: Deal or Dilution?
[View article]
ZIOP filed a shelf this AM. The stock reacted as anticipated. I am not sure if the shelf is designed to push a deal along or if they...
More »
Comment by
Wall Street Teacher
Aug 20 22:26 pm
|
Rating:
0
0
Ziopharm Oncology: Deal or Dilution?
[View article]
Wall St. Teacher: Though I primarily focus my attention on optionable company's with later-stage products, ZIOP does appear to have...
More »
Comment by
Justin M. Hall
Aug 19 21:51 pm
|
Rating:
0
0
Ziopharm: The Money's in the Bank, So What's Next? [View article]
Ziopharm: The Money's in the Bank, So What's Next? [View article]
Ziopharm: The Money's in the Bank, So What's Next? [View article]
Ziopharm: The Money's in the Bank, So What's Next? [View article]
Ziopharm Oncology: Step by Step [View article]
Buyout Buzz at ASH Hematology Confab [View article]
Ziopharm Oncology: Step by Step [View article]
Ziopharm Oncology: Step by Step [View article]
Ziopharm Oncology: Step by Step [View article]
Ziopharm Oncology: Step by Step [View article]
BioMed News Bytes: Progenics, Somanetics, Ziopharm, Cardium, pSivida, BioMimetic Therapeutics [View article]
BioMed News Bytes: Progenics, Somanetics, Ziopharm, Cardium, pSivida, BioMimetic Therapeutics [View article]
BioMed News Bytes: Progenics, Somanetics, Ziopharm, Cardium, pSivida, BioMimetic Therapeutics [View article]
Ziopharm Oncology: Deal or Dilution? [View article]
Ziopharm Oncology: Deal or Dilution? [View article]